Head-To-Head Review: Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and Tilray (NASDAQ:TLRY)

Tilray (NASDAQ:TLRY) and Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.

Institutional and Insider Ownership

9.4% of Tilray shares are owned by institutional investors. 0.9% of Tilray shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Tilray and Synergy CHC Corp. (Uplisting)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tilray	-30.95%	-4.40%	-3.57%
Synergy CHC Corp. (Uplisting)	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent recommendations for Tilray and Synergy CHC Corp. (Uplisting), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray	0	3	2	0	2.40
Synergy CHC Corp. (Uplisting)	0	0	1	1	3.50

Tilray currently has a consensus target price of $2.70, suggesting a potential upside of 318.93%. Synergy CHC Corp. (Uplisting) has a consensus target price of $10.00, suggesting a potential upside of 179.33%. Given Tilray’s higher possible upside, equities research analysts plainly believe Tilray is more favorable than Synergy CHC Corp. (Uplisting).

Valuation and Earnings

This table compares Tilray and Synergy CHC Corp. (Uplisting)”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray	$210.48 million	2.87	-$244.98 million	($0.30)	-2.15
Synergy CHC Corp. (Uplisting)	$26.01 million	1.20	N/A	N/A	N/A

Synergy CHC Corp. (Uplisting) has lower revenue, but higher earnings than Tilray.

Summary

Tilray beats Synergy CHC Corp. (Uplisting) on 6 of the 11 factors compared between the two stocks.

About Tilray

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

About Synergy CHC Corp. (Uplisting)

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.